Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumeng Mao

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|October 12, 2019
What industry can teach academiaYumeng Mao
Frontiers in Immunology|July 19, 2021
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer ImmunotherapyErik Wennerberg, Andreas Lundqvist, Yumeng Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
Myeloid suppressors decrease melanoma survival by abating tumor-fighting T cellsRolf Kiessling, Yumeng Mao, Yago Pico de Coaña
Briefings in Bioinformatics|August 21, 2022
LRTCLS: low-rank tensor completion with Laplacian smoothing regularization for unveiling the post-transcriptional machinery of N6-methylation (m6A)-mediated diseasesJiani Ma, Hui Liu, Yumeng Mao, et al.
Journal of Translational Medicine|November 19, 2013
Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypesIsabel Poschke, Yumeng Mao, Rolf Kiessling, et al.
Current Medicinal Chemistry|June 29, 2019
The Next Generation of Pattern Recognition Receptor Agonists: Improving Response Rates in Cancer ImmunotherapyDaniel H O' Donovan, Yumeng Mao, Deanna A Mele
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockadeMarina Natoli, Nair Bonito, James D Robinson, et al.
Quantitative Imaging in Medicine and Surgery|January 15, 2024
Choline as a specific manifestation of delayed encephalopathy after acute carbon monoxide poisoning: a description of two casesHuige Zhai, Yumeng Mao, Qianqi Wang, et al.
Oncoimmunology|December 18, 2012
Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patientsJana de Boniface, Yumeng Mao, Jan Schmidt-Mende, et al.
Cancer Immunology, Immunotherapy : CII|March 23, 2020
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockadeMarina Natoli, Nair Bonito, James D Robinson, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|October 12, 2019
What industry can teach academiaYumeng Mao
Frontiers in Immunology|July 19, 2021
Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer ImmunotherapyErik Wennerberg, Andreas Lundqvist, Yumeng Mao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2014
Myeloid suppressors decrease melanoma survival by abating tumor-fighting T cellsRolf Kiessling, Yumeng Mao, Yago Pico de Coaña
Briefings in Bioinformatics|August 21, 2022
LRTCLS: low-rank tensor completion with Laplacian smoothing regularization for unveiling the post-transcriptional machinery of N6-methylation (m6A)-mediated diseasesJiani Ma, Hui Liu, Yumeng Mao, et al.
Journal of Translational Medicine|November 19, 2013
Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypesIsabel Poschke, Yumeng Mao, Rolf Kiessling, et al.
Current Medicinal Chemistry|June 29, 2019
The Next Generation of Pattern Recognition Receptor Agonists: Improving Response Rates in Cancer ImmunotherapyDaniel H O' Donovan, Yumeng Mao, Deanna A Mele
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Correction to: Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockadeMarina Natoli, Nair Bonito, James D Robinson, et al.
Quantitative Imaging in Medicine and Surgery|January 15, 2024
Choline as a specific manifestation of delayed encephalopathy after acute carbon monoxide poisoning: a description of two casesHuige Zhai, Yumeng Mao, Qianqi Wang, et al.
Oncoimmunology|December 18, 2012
Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patientsJana de Boniface, Yumeng Mao, Jan Schmidt-Mende, et al.
Cancer Immunology, Immunotherapy : CII|March 23, 2020
Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockadeMarina Natoli, Nair Bonito, James D Robinson, et al.
Pageof 4